| First Author | Eberle JU | Year | 2019 |
| Journal | J Invest Dermatol | Volume | 139 |
| Issue | 9 | Pages | 1957-1965.e2 |
| PubMed ID | 30910757 | Mgi Jnum | J:283887 |
| Mgi Id | MGI:6387887 | Doi | 10.1016/j.jid.2019.03.1129 |
| Citation | Eberle JU, et al. (2019) Eosinophils Mediate Basophil-Dependent Allergic Skin Inflammation in Mice. J Invest Dermatol 139(9):1957-1965.e2 |
| abstractText | The mechanisms leading to allergic skin inflammation, such as atopic dermatitis or urticaria, are poorly defined. Here we used a mouse model for IgE-dependent chronic allergic inflammation to study the role of basophils and eosinophils for induction of pathology. FcepsilonRI expression in basophils was required for the ear swelling response, and basophils promoted the expression of eosinophil-recruiting chemokines in the ear. The ear swelling response could be prevented by prior infection of mice with helminths in an IgE-dependent manner. Impaired skin eosinophilia and reduced ear swelling was further observed in IL-4/IL-13-deficient and STAT6-deficient mice. In addition, eosinophil-deficient DeltadblGATA mice showed only weak ear swelling response, which could be enhanced by eosinophil transfer. This suggests that IgE-activated basophils orchestrate the recruitment of eosinophils by secretion of IL-4/IL-13, which leads to STAT6-dependent expression of CCL24 from endothelial cells and extravasation of eosinophils into the ear pinna. Eosinophils are then the critical effector cells that cause pathology. Therefore, combined therapeutic approaches that block basophil activation and reduce eosinophil numbers could be efficient strategies to improve treatment of chronic allergic disorders of the skin. |
